Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial thiol-containing enzymes and membrane proteins represent a diverse group of targets essential for the survival and pathogenesis of bacteria, fungi, and viruses. These proteins rely on reactive thiol (sulfhydryl) groups, primarily from cysteine residues, for catalytic activity, structural stability, and transport functions [1: https://pubmed.ncbi.nlm.nih.gov/11030646/]. Antimicrobial agents such as silver ions, mercurials, and certain oxidizing agents target these groups by forming covalent bonds or inducing oxidative stress, which leads to the denaturation of critical enzymes like those in the respiratory chain and the disruption of membrane-bound transport systems [2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292600/]. This broad-spectrum mechanism of action is highly effective for topical applications, such as the use of silver sulfadiazine in burn wound management to prevent sepsis [3: https://go.drugbank.com/drugs/DB01015]. However, the lack of high specificity for microbial versus host thiols presents a therapeutic challenge, often restricting these agents to external use to avoid systemic toxicity [4: https://pubchem.ncbi.nlm.nih.gov/compound/Silver-nitrate]. Furthermore, the emergence of resistance mechanisms, such as the production of thiol-sequestering proteins or efflux pumps, continues to be a focus of clinical monitoring [5: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037531/].
Covalent binding to sulfhydryl (-SH) groups, resulting in protein denaturation, enzyme inactivation, and disruption of membrane integrity and cellular respiration.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial thiol-containing enzymes and membrane proteins.